麻豆传媒

Alistair Smith is a professor and chair of the Department of Earth and Spatial Sciences at University of Idaho. He's an internationally recognized leader in wildland fire science and is an expert in pyroecophysiology, a new sub-field of fire ecology that he termed in 2017 that focuses on understanding how fires affect trees, why some die and, when they survive, what happens to them. His team’s research has had a major impact on changing the understanding of fire ecology, especially in the face of more intense and frequent fires under climate change.
Available to speak on: 
Forest fire ecology
Fire behavior
Smoke management

, is a gynecologic oncologist who specializes in the surgical management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive surgery, chemotherapy and novel drugs.
Eskander is also experienced in clinical trial development and aims to provide individuals with access to innovative medicines during their treatment. He is a member of  and the clinical trials office director for oncology.
As an assistant professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California San Diego, Eskander instructs medical students, residents and fellows. His research focuses on immunotherapy, targeted therapies for treating clear cell and endometrioid ovarian cancer, quality of life in cancer patients, and end-of-life care.
Eskander speaks Arabic and Spanish fluently.

, is a board-certified infectious disease specialist who cares for patients with general infectious diseases. She serves as medical director of sustainability at UC San Diego Health, supporting efforts to adapt practices to best promote health of patient and planet. Abeles also serves as medical program director of antimicrobial stewardship at UC San Diego Health, and as associate medical program director of infection prevention / clinical epidemiology.
As an associate professor at UC San Diego School of Medicine, she is involved in the training and education of medical students, residents, and fellows in the Division of Infectious Diseases and Global Public Health. Her research focuses on evaluating methods for curbing unnecessary antibiotic use in health care settings as well as assessing the clinical impacts of various infection prevention interventions.
She is also board certified in internal medicine.

Daryl Friedman is global president and CEO of CEDIA, the Association for Smart Home Professionals™. Daryl is an expert on connected home issues, from emerging technology and smart home trends to the labor shortage for skilled trades and the standards and best practices that guide the industry.
Under his leadership, CEDIA has experienced record-breaking new membership acquisition rates, with members now represented in over 80 countries. As a result, he can speak to the global adoption of smart home integration as well as differences across countries and regions in trends, interconnectivity policies, privacy issues and more. He has also expanded the association’s advocacy efforts and can speak to how CEDIA promotes policies that advance the interests of the smart home industry while protecting integrators. 
A nonprofit and association executive for more than 30 years, Friedman also has experience leading branding campaigns as well as advising members of Congress and coalition partners. He previously held a senior leadership role at the Grammy Awards where he oversaw membership, industry relations, advocacy and the recording engineer's wing. He received his M.A. in arts management from American University in Washington, D.C., and his B.A. in economics from the University of California, Santa Cruz.

Shannon Conley, Ph.D., is a researcher and faculty member in the Department of Cell Biology at the University of Oklahoma College of Medicine. She has worked in age-related diseases and smooth muscle cell biology for more than 10 years and has published more than 90 research articles. During her graduate and postgraduate training, she gained extensive experience and skill sets in neuronal and vascular diseases in the aging eye. Her early work on vascular and degenerative diseases prompted her to pursue her research interests in vascular smooth muscle cell biology in the aging brain and to establish her sustainable, independent NIH-funded research program. Since obtaining her first faculty position in 2012, one of her greatest pleasures is working one-on-one with students in the lab to help them learn technical, analytical, writing, communication and professional skills. She has mentored students at a variety of levels. Conley earned her doctorate from the Department of Pharmacology and Toxicology at the University of Arizona, and she completed a postdoctoral fellowship in cell biology at the OU College of Medicine. She is a member of the International Society for Cerebral Blood Flow and Metabolism, the American Aging Association, and the Association for Research in Vision and Ophthalmology. She is associate editor of the journal GeroScience.

Suresh Acharya has spent over 25 years designing and building statistical and optimization solutions in the areas of Supply Chain Management, Retail Planning, Airline Operations, Logistics, and Pricing and Revenue Management. As a practicing analytics professional, he continues to work with Fortune 500 companies in delivering practical algorithmic solutions that demonstrate measurable customer value.

, MD, PhD, is a sought-after expert in food allergy, eosinophilic gastrointestinal disease, and eczema (atopic dermatitis). As Chief of the Allergy Program at Children's Hospital of Philadelphia (CHOP), he focuses on improving the quality of life for children with allergies and related conditions.
He is also the Director of the Center for Pediatric Eosinophilic Disorders, Stuart E. Starr Chair of Pediatrics at CHOP and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.
Spergel has led multicenter clinical trials for food allergy, EoE, or atopic dermatitis sponsored by NIH, PCORI, industry, foundations, and academic partners. His research identified the role of genetics, foods and t-cells in eosinophilic esophagitis and found that  can be outgrown.

Bruce (he/him) is the founder and president of , an international network of organizations working to advance alternative proteins to help meet global climate, public health, food security, and biodiversity goals. Bruce is one of the leading global experts on alternative proteins, and currently oversees GFI’s global strategy, working with teams across Asia Pacific, Brazil, Europe, India, Israel, and the U.S. Bruce is an expert on food innovation, especially when it comes to feeding a growing population (with a growing demand for protein), in ways that are sustainble and equitable. Bruce is a TED Fellow, Y Combinator alum, 2021 “American Food Hero” (), and has penned op-eds for the Wall Street Journal, Foreign Policy, CNN, Nature Food, Los Angeles Times, Wired. He has also represented GFI on the TED Radio Hour, New Yorker Radio Hour, Ezra Klein Show, and Making Sense (Sam Harris). Bruce’s  has been viewed 2.4 million times and translated into 30 languages. He graduated magna cum laude from Georgetown Law and also holds degrees from Johns Hopkins University and the London School of Economics. 

Elliot (he/him) is one of the leading scientists studying cultivated meat and alternative proteins. His work focuses on analyzing the technical and economic bottlenecks facing the cultivated meat industry, identifying opportunities to accelerate the industry, and educating scientists, the public, and other industry stakeholders. For the past five years, Elliot has worked on projects ranging from food safety and environmental impact to in-depth analysis of the cultivated meat value chain. Elliot's expertise has been cited in , ,  , and .
Elliot holds a Ph.D. in neuroscience from the University of California, Los Angeles (UCLA), where he worked with induced pluripotent stem cells to model neuromuscular disease.

Priera (she/her) is passionate about leveraging science and technology to advance food security, improve environmental sustainability, and ensure equitable access and flourishing livelihoods for producers across food and agricultural value chains. Her role at the Good Food Institute focuses on accelerating the plant-based meat industry by analyzing the plant-based protein landscape, identifying emerging technological solutions and bottlenecks, and communicating with other scientists about advancing alternative protein research. She aims to take a “big tent” approach to food system transformation—strongly advocating for inclusive solutions that provide opportunities for farmers, processors, food manufacturers, and consumers alike. Priera has also applied her chemistry background to address issues of minimizing food waste, improving water use in agriculture, reducing agricultural chemical runoff, and, currently, optimizing the sustainability of our global protein supplies. 
Priera has bachelor’s degrees in chemistry and math from the University of California, Santa Cruz as well as a master’s and a doctorate in organic chemistry from the University of California, Los Angeles. Prior to joining the Good Food Institute, Priera spent almost a decade focusing on polymer, formulation, and materials chemistry research. Particularly, she honed these skills for food security applications by creating novel sustainable agriculture materials and compounds.

Jessica heads up the Washington D.C. office for , where our team of lawyers, analysts and policy experts leverage federal and state legislation, regulation, litigation, and multilateral engagement to secure public investments and ensure a level playing field for alternative proteins. Jessica has expertise in the U.S. regulatory landscape for alternative proteins (including cultivated/lab grown meat and plant based foods), and can also speak to how governments around the world are choosing to invest in alternative proteins. Prior to GFI, she advanced the public interest through policy and litigation at the Center for Science in the Public Interest and the D.C.-based law firm Meyer Glitzenstein & Crystal. Jessica holds a J.D. from New York University School of Law and an M.S. in Animals and Public Policy from Tufts University.

Dr. Lindaman is an assistant professor at Assistant Professor in the Department of Rehabilitation Science at Tufts University School of Medicine and a faculty member in the Doctor of Physical Therapy Program (Seattle), serving as their primary course director for the clinical neuroscience and neuromuscular practice management courses. Prior to joining Tufts, he served as the course director for the neurological rehabilitation courses at Drexel University. Clinically, he completed his neurological physical therapy residency at Thomas Jefferson University and Magee Rehabilitation Hospital in 2018. He worked as a full-time clinician for Good Shepherd Penn Partners (GSPP) University City in their outpatient site located in Philadelphia from 2018-2023, primarily working with a variety of neurological, orthopedic, and vestibular-related diagnoses. He also served as a clinical instructor. He is recognized by the APTA/Duke University as being vestibular rehabilitation competent. His research agenda is focused on clinical reasoning patterns along with student success within DPT education. Professionally, he has served as the chair of the neurological special interest group for the APTA Pennsylvania Chapter and as a House of Delegate. representative. He currently serves on the Committee of Content Experts (CCE) for the American Board of Physical Therapist Specialist to develop testing questions for the neurological clinical specialty exam.

Jeffrey Foucrier is an assistant professor in the Department of Rehabilitation Science at Tufts University School of Medicine and a faculty member in the Doctor of Physical Therapy Program (Phoenix).

Clinical areas of expertise are Gamma Knife stereotactic radiosurgery, SBRT, Central Nervous System, Head and Neck, Lung, Lymphoma, Skin, GI, GU.

Michael Clarke is a faculty member in Department of Rehabilitation Science at Tufts University School of Medicine who teaches in the Tufts Doctor of Physical Therapy Program (Seattle). With a board certification as an orthopedic clinical specialist through the American Board of Physical Therapy Specialties, and as a fellow of the American Academy of Orthopaedic Manual Physical Therapists, he brings a depth of expertise to his teaching. He is the primary instructor for courses in Physical Therapy Fundamentals, Upper Quarter Musculoskeletal Management, and Primary Care, focusing on integrating advanced practice techniques and evidence-based care. His commitment to the profession extends beyond the classroom, serving as the chair of the Nominating Committee for the APTA Idaho Chapter. Recognized for his exceptional contributions and leadership in the field, he was honored as the Physical Therapist of the Year in 2022 by the APTA Idaho.

's interdisciplinary research improves animal and human gastrointestinal and mental health. By understanding how environmental factors such as nutrition and stress alter communication between the resident microbiota, intestine, and brain, his work strives to formulate dietary interventions that reduce gastrointestinal symptoms during functional gastrointestinal disorders, psychological stress, and cancer.
Affiliations: Loman is an assistant professor in the , part of the  (ACES) at the . He is affiliated with the , also part of ACES, and the . 

, is a board-certified urologist who specializes in detecting, treating and preventing genitourinary cancer. He is experienced in surgical and nonsurgical treatments for all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile and testicular cancers. He also has expertise in minimally invasive approaches to urologic surgery.
As an associate professor in the Department of Urology, Bagrodia trains medical students, residents and fellows at University of California San Diego School of Medicine, where he leads the genitourinary disease team. He has focused his clinical and research interests on understanding molecular attributes of germ cell tumors, which cause testicular cancer, with the goal of ultimately improving treatments and clinical care. He also has been actively involved in understanding and overcoming societal and epidemiological barriers to optimal care in testicular cancer patients.
Bagrodia, , has been involved in clinical trials for patients with testicular cancer and has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He has been funded through intramural research grants and also via competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health.
He is the principal author or co-author of more than 150 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. Dr. Bagrodia is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology and the Annals of Surgical Oncology. He also has contributed to several textbooks.
He also speaks Hindi.

Grant Harley’s research interests lie within the broad domain of physical geography, but focus on climatology, biogeography, and paleoenvironmental reconstruction over the past ca. 2,000 years. Currently the overarching goal of Grant’s research program is focused on integrating information about current and past climatic and ecological processes to better understand how natural resources (like plant communities and water) are likely to become altered in the future due to human-induced changes. Grant uses dendrochronology and spatial analysis as research tools to investigate landscape鈥恠cale dynamics (those initiated and/or controlled by both human and natural processes), which must be tempered with a historical perspective.
Topics: climate change, drought, hot-droughts, floods, avalanches, snowpack, atmospheric rivers, wildfires, river discharge, forest ecology, insect outbreaks, dendrochronology (tree-ring science)

, is a board-certified general and plastic surgeon who specializes in all aspects of breast health, with a focus on breast cancer and breast reconstruction. She directs UC San Diego Health's , which offers premier breast cancer detection, diagnosis, and personalized care. Wallace's other specialties include melanoma diagnosis and treatment, as well as all forms of cosmetic breast and body contouring surgery. Wallace also has expertise in providing gender-affirming care to transgender and nonbinary patients.
Wallace is a professor in the University of California San Diego School of Medicine Department of Surgery and is very involved in teaching medical students, residents, fellows and colleagues. Her research focus has been in the development of molecular targeted imaging agents used for the detection of breast cancer and melanoma. She has also led the breast health center team in building a large scale clinical trials program, including novel neoadjuvant therapies and risk management.
Wallace is sought for her presentations on breast health, prevention, surgical intervention and reconstruction by local and national organizations. She also contributes professionally to many cancer leadership services and UC San Diego committees and is a member of the .

, is a board-certified vascular neurologist. His expertise includes caring for patients with stroke, cerebrovascular diseases, and those who require neurological critical care. Hemmen directs the Comprehensive Stroke Center at UC San Diego Health and was instrumental in establishing the center as the first certified Stroke Center of Excellence in San Diego County.
As a professor at the University of California School of Medicine Department of Neurosciences, Hemmen directs the Stroke Fellowship Program and provides leadership and education to medical students, residents and fellows.
Hemmen is the lead investigator for numerous clinical trials in cerebrovascular disease. He investigates the use of neuroprotection and reperfusion therapies after acute ischemic stroke, as well as stroke prevention, recovery and research in intracerebral hemorrhage. He also leads the cerebrovascular research and trial coordination center that conducts national and international collaborative trials and researches new cures in all areas of cerebrovascular medicine.